305 related articles for article (PubMed ID: 2138366)
41. Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies.
Kimball P; Rhodes C; King A; Fisher R; Ham J; Posner M
Transplantation; 1998 Feb; 65(3):444-6. PubMed ID: 9484770
[TBL] [Abstract][Full Text] [Related]
42. Improved graft survival in cadaveric renal retransplantation by flow crossmatching.
Nelson PW; Eschliman P; Shield CF; Aeder MI; Luger AM; Pierce GE; Bryan CF
Arch Surg; 1996 Jun; 131(6):599-603. PubMed ID: 8645065
[TBL] [Abstract][Full Text] [Related]
43. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
Heise ER; Thacker LR; MacQueen JM; Peters TG
Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
[TBL] [Abstract][Full Text] [Related]
44. A retrospective flow cytometric crossmatch study in transplant recipients with autoreactive lymphocytotoxic antibodies.
Martin S; Davies MS; Robson AJ
Transpl Int; 1994; 7 Suppl 1():S527-31. PubMed ID: 11271299
[TBL] [Abstract][Full Text] [Related]
45. Crossmatch tests--an analysis of UNOS data from 1991-2000.
Cho YW; Cecka JM
Clin Transpl; 2001; ():237-46. PubMed ID: 12211787
[TBL] [Abstract][Full Text] [Related]
46. Sensitization.
Ogura K
Clin Transpl; 1992; ():357-69. PubMed ID: 1306712
[TBL] [Abstract][Full Text] [Related]
47. Flow cytometric crossmatch for kidney transplantation.
Koktathong K; Vejbaesya S; Bejrachandra S; Pattanapanyasat K
J Med Assoc Thai; 2005 Jun; 88(6):769-74. PubMed ID: 16083217
[TBL] [Abstract][Full Text] [Related]
48. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
[TBL] [Abstract][Full Text] [Related]
49. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.
Böhmig GA; Exner M; Habicht A; Schillinger M; Lang U; Kletzmayr J; Säemann MD; Hörl WH; Watschinger B; Regele H
J Am Soc Nephrol; 2002 Apr; 13(4):1091-1099. PubMed ID: 11912271
[TBL] [Abstract][Full Text] [Related]
50. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
[TBL] [Abstract][Full Text] [Related]
52. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
54. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
55. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
56. Posttransplant donor-specific antibody characterization and kidney graft survival.
Piazza A; Borrelli L; Monaco PI; Poggi E; Pisani F; Valeri M; Fraboni D; Servetti S; Casciani CU; Adorno D
Transpl Int; 2000; 13 Suppl 1():S439-43. PubMed ID: 11112049
[TBL] [Abstract][Full Text] [Related]
57. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
[TBL] [Abstract][Full Text] [Related]
58. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
[TBL] [Abstract][Full Text] [Related]
59. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
60. Association between flow cytometric crossmatching and graft survival in Thai cadaveric-donor kidney transplantation.
Kupatawintu P; Tatawatorn A; Premasathian N; Avihingsanon Y; Leelahavanichkul A; Hirankarn N
Asian Pac J Allergy Immunol; 2016 Mar; 34(1):86-93. PubMed ID: 26994631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
